UNSPSC 51282305: Erythromycin ethylcarbonate

This classification denotes a macrolide antibiotic with the molecular formula C37H67NO13.C3H6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D2JUE6GD5A. Most nations schedule erythromycin ethylcarbonate under HS 29415000 and SITC 54139. As of Q4 2014, ERYTHROMYCIN ETHYLCARBONATE remains the US FDA Preferred Term for this commodity. Erythromycin ethylcarbonate bears US NLM identifiers UMLS ID C2700011 and NCI Concept Code C76762.

SMILES: CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)OCC)(C)O)C)C)O)(C)O.

UNSPSC 51282305 Erythromycin ethylcarbonate is a Commodity code that nominally specifies a single antibiotic product, but recent state and local solicitations tagged under this code show minimal alignment with the code's specific scope. The opportunities that do reference this code segment predominantly solicit broader medical and pharmaceutical products—emergency medical supplies, naloxone, first-aid materials, and multi-source generic pharmaceuticals for health systems and emergency responders—rather than erythromycin ethylcarbonate specifically. State and local buyers using this code appear to include county health departments, municipal fire and rescue divisions, and statewide cooperative purchasing alliances managing pharmacy benefit programs and emergency medical stockpiles.

Recent opportunities span Florida, Texas, Minnesota, and associated cooperative purchasing jurisdictions. Seminole County, Florida posted an IFB in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with responses due July 26, 2023, for quarterly delivery to the county community health building. The City of Tampa issued an IFB in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with a response deadline of March 13, 2026, an estimated contract value of $700,000, and a five percent bid discount available for certified Small Local Business Enterprises. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP in January 2026 for generic multi-source pharmaceuticals and over-the-counter products across participating state and local facilities in Minnesota, Oregon, and other member jurisdictions, with responses due March 26, 2026. The Texas Health and Human Services Commission issued a Request for Information in April 2026 regarding direct-to-manufacturer prescription fulfillment capabilities for state pharmacy benefit programs. The code shows limited recent activity aligned with erythromycin ethylcarbonate as a specific pharmaceutical commodity.